CClinicalTrials.gg
CompletedNCT00283569Updated Jan 20, 2010

Genetic Epidemiology of Adult Onset Glioma

An observational study in Adult-Onset Glioma, sponsored by Kentuckiana Cancer Institute. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2010-01-20.

Sponsored by Kentuckiana Cancer Institute · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

To establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors.

Read the detailed description

Genetic epidemiology of adult glioma to establish potential risk factors for primary adult brain tumors.

02

Conditions studied

  • Adult-Onset Glioma

Browse trials for

Keywords

  • Glioma
03

In context

Glioma

1,397 studies on the registry are indexed under Glioma; 351 are open to participants now.

This study's planned enrollment of 100 is above the median of 88 across 238 observational studies indexed under Glioma.

Browse Glioma studies →

Lead sponsor

Kentuckiana Cancer Institute is the lead sponsor of 7 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients with Glioma and a Control

Eligibility criteria

Inclusion Criteria:

  • primary glioma of any stage
  • diagnosed within 4 months
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
100 participants (estimated)
Biospecimen retention
Samples with dna

Interventions

  • OtherMouth Swab, Toe Nail Clippings, Questionnaires

    The objective of this study is to establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors.

06

Study locations

1 site
  • Kentuckiana Cancer Institute
    Louisville, Kentucky 40202, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 20, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00283569
Lead sponsor
Kentuckiana Cancer Institute
Collaborators
DR. Kathleen Egan
First posted
Jan 30, 2006
Start date
May 2004
Primary completion
Jan 2010
Completion
Jan 2010
Last update
Jan 20, 2010

Study contacts

Renato V. LaRocca, MD
principal investigator · Director
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion